Sex-specific determinants of HIV infection among injection drug users in Montreal
- PMID: 11276542
- PMCID: PMC80871
Sex-specific determinants of HIV infection among injection drug users in Montreal
Abstract
Background: Sex-specific issues have not been extensively addressed in studies of HIV prevalence, despite the strong implications of differences between men and women in the risk of HIV transmission. The objective of this study was to examine sex-specific behaviours associated with HIV infection among injection drug users in Montreal.
Methods: A total of 2741 active drug users (2209 [80.6%] men) were recruited between 1988 and 1998. Information was sought on sociodemographic characteristics, drug-related behaviour and sexual behaviour, and participants were tested for HIV antibodies. Sex-specific independent predictors of HIV prevalence were assessed by stepwise logistic regression.
Results: The overall prevalence of HIV among study subjects was 11.1%; the prevalence was 12.0% among men and 7.5% among women. In multivariate models, a history of sharing syringes with a known seropositive partner (odds ratio [OR] for men 2.44, 95% confidence interval [CI] 1.72-3.46; OR for women 3.03, 95% CI 1.29-7.13) and of sharing syringes in the past 6 months (OR for men 0.61, 95% CI 0.44-0.85; OR for women 0.32, 95% CI 0.14-0.73) were independently associated with HIV infection. Other variables associated with HIV infection were homosexual or bisexual orientation, cocaine rather than heroin as drug of choice, frequency of injection drug use, and obtaining needles at a pharmacy or through needle exchange programs (for men only) and obtaining needles at shooting galleries and being out of treatment (for women only).
Interpretation: These results support the hypothesis that risk factors for HIV seropositivity differ between men and women. These sex-related differences should be taken into account in the development of preventive and clinical interventions.
References
-
- Archibald CP, Remis RS, Williams G, Farley J, Albert T, Yan P, et al. Estimating current prevalence and incidence of HIV in Canada [plenary session]. Sixth Annual Canadian Conference on HIV/AIDS Research; May 1997; Ottawa.
-
- Division of HIV/AIDS Surveillance, Bureau of HIV/AIDS, STD and Tuberculosis, Laboratory Centre for Disease Control. HIV and AIDS in Canada. Surveillance report to December 31, 1998. Ottawa: Health Canada; 1999. p. 30.
-
- Anthony JC, Vlahov D, Nelson KE, Cohn S, Astemborski J, Solomon L. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am JEpidemiol 1991;134(10):1175-89. - PubMed
-
- Hudgins R, McCusker J, Stoddard A. Cocaine use and risky injection and sexual behaviours. Drug Alcohol Depend 1995;37:7-14. - PubMed
-
- Schoenbaum EE, Hartel D, Selwyn P, Klein RS, Davenny K, Rogers M, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med 1989;321:874-9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous